Orphan drugs in Australia

被引：5

作者：

Herkes, Geoffrey K. ^{[1
,2
,3
]}

机构：

[1] Royal North Shore Hosp, Dept Neurol, St Leonards, NSW, Australia

[2] Univ Sydney, Kolling Inst, Med, Sydney, NSW, Australia

[3] Advisory Comm Prescript Med Therapeut Goods Adm, Canberra, ACT, Australia

来源：

EXPERT OPINION ON ORPHAN DRUGS | 2016年 / 4卷 / 12期

关键词：

Orphan drug program; review; rare diseases; oncology;

D O I：

10.1080/21678707.2016.1257383

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1195 / 1197

页数：3

共 50 条

[11] ORPHAN DRUGS
不详
SOUTH AFRICAN MEDICAL JOURNAL, 1983, 63 (24): : 914 - 914
[12] ORPHAN DRUGS
Fontanet Sacristan, Juan Manuel
Torrent-Farnell, Josep
ARBOR-CIENCIA PENSAMIENTO Y CULTURA, 2018, 194 (789)
[13] Orphan drugs
Novack, Gary D.
OCULAR SURFACE, 2008, 6 (01): : 52 - 55
[14] Orphan drugs and orphan tests in the USA
Thoene, JG
COMMUNITY GENETICS, 2004, 7 (04) : 169 - 172
[15] Development of Orphan Drugs in Japan: Characteristics of Orphan Drugs Developed in Japan
Makoto Shiragami
Kiyohito Nakai
Drug information journal : DIJ / Drug Information Association, 2000, 34 (3): : 839 - 846
[16] Development of orphan drugs in Japan: Characteristics of orphan drugs developed in Japan
Shiragami, M
Nakai, K
DRUG INFORMATION JOURNAL, 2000, 34 (03): : 839 - 846
[17] A COMPARATIVE STUDY OF ACCESS TO ORPHAN DRUGS AND ORPHAN DRUGS REGULATIONS AND POLICIES
Ounsirithupsakul, T.
Samphansompoch, T.
Sermsakulthai, T.
Taychakhoonavudh, S.
VALUE IN HEALTH, 2018, 21 : S49 - S49
[18] ORPHAN DISEASES AND ORPHAN DRUGS - SCHEINBERG, WALSHE
QURESHI, B
JOURNAL OF THE ROYAL SOCIETY OF HEALTH, 1987, 107 (04): : 160 - 160
[19] Orphan drugs for myelofibrosis
Harrison, Claire N.
Bennett, Michael
EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (04): : 391 - 405
[20] The problem of orphan drugs
Ferner, Robin E.
Hughes, Dyfrig A.
BRITISH MEDICAL JOURNAL, 2010, 341